Skip to main content
. 2021 Jun 10;8:674850. doi: 10.3389/fvets.2021.674850

Figure 5.

Figure 5

Effect of Flu Avert treatment on chemokine mRNA expression in ERECs collected from five horses 48 h following EHV-1 inoculation. (A) IL-8 mRNA expression in ERECs that were treated with Flu Avert on day 1 prior to EHV-1 inoculation. (B) IL-8 mRNA expression in ERECs that were treated with Flu Avert on day 2 prior to EHV-1 inoculation. (C) IL-8 mRNA expression in ERECs that were treated with Flu Avert on day 5 prior to EHV-1 inoculation. (D) IL-8 mRNA expression in ERECs that were treated with Flu Avert on day 7 prior to EHV-1 inoculation. (E) CCL2 mRNA expression in ERECs that were treated with Flu Avert on day 1 prior to EHV-1 inoculation. (F) CCL2 mRNA expression in ERECs that were treated with Flu Avert on day 2 prior to EHV-1 inoculation. (G) CCL2 mRNA expression in ERECs that were treated with Flu Avert on day 5 prior to EHV-1 inoculation. (H) CCL2 mRNA expression in ERECs that were treated with Flu Avert on day 7 prior to EHV-1 inoculation. The mean log fold change (–ddCq) is represented by a bar (**p < 0.01 and *p < 0.05).